← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1	Vanguard Group Malvern, Pennsylvania	$56.4B	+$60M	126	1.39%	Increased
2	BlackRock New York	$50.4B	-$2.4B	138	1.45%	Reduced
3	State Street Boston, Massachusetts	$25.8B	-$971M	125	1.43%	Reduced
4	Fidelity Investments Boston, Massachusetts	$25.8B	-$159M	108	2.23%	Reduced
5	Capital World Investors Los Angeles, California	$16.1B	-$281M	12	3.2%	Reduced
6	Morgan Stanley New York	$15.6B	-$1.28B	146	1.59%	Reduced
7	T. Rowe Price Associates Baltimore, Maryland	$14.7B	+$538M	80	2.15%	Increased
8	Wellington Management Group Boston, Massachusetts	$14.4B	+$1.49B	36	2.88%	Increased
9	JP Morgan Chase New York	$12.9B	+$834M	133	1.43%	Increased
10	Geode Capital Management Boston, Massachusetts	$12.2B	+$201M	144	1.46%	Increased
11	T. Rowe Price Investment Management Baltimore, Maryland	$8.33B	+$11.8M	20	5.89%	Increased
12	Norges Bank Oslo, Norway	$8B	-$194M	43	1.62%	Reduced
13	Capital International Investors Los Angeles, California	$7.52B	+$380M	12	1.91%	Increased
14	Massachusetts Financial Services Boston, Massachusetts	$7.15B	-$712M	18	2.5%	Reduced
15	Bank of America Charlotte, North Carolina	$7.05B	-$441M	132	0.78%	Reduced
16	Capital Research Global Investors Los Angeles, California	$6.94B	+$975M	9	1.91%	Increased
17	Northern Trust Chicago, Illinois	$6.94B	+$127M	123	1.34%	Increased
18	Bank of New York Mellon New York	$6.49B	+$152M	103	1.43%	Increased
19	Janus Henderson Group London,	$5.52B	+$180M	57	3.61%	Increased
20	Franklin Resources San Mateo, California	$4.52B	+$89.7M	55	2.3%	Increased
21	Goldman Sachs New York	$4.4B	+$450M	100	0.94%	Increased
22	Dodge & Cox San Francisco, California	$4.29B	-$39.5M	5	2.89%	Reduced
23	Legal & General Group London, United Kingdom	$4.17B	-$133M	80	1.45%	Reduced
24	Baillie Gifford & Co Edinburgh, United Kingdom	$4.16B	-$644M	15	3.8%	Reduced
25	Charles Schwab San Francisco, California	$4.15B	+$1.88M	93	1.19%	Increased